Daphnoretin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells

Shoubin Gu1, Jinhai He

  • 1Department of Orthopaedics, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China. shoubingu@sina.com

Insights

Daphnoretin effectively inhibits human osteosarcoma (HOS) cell proliferation by inducing cell cycle arrest in the G2/M phase and triggering apoptosis through the caspase-3 pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Human osteosarcoma (HOS) is a primary bone cancer with limited treatment options.
  • Identifying novel therapeutic agents with antiproliferative and pro-apoptotic properties is crucial.

Purpose of the Study:

  • To investigate the antiproliferative, cell cycle arrest, and apoptosis-inducing effects of daphnoretin in HOS cells.
  • To elucidate the underlying molecular mechanisms of daphnoretin-induced cell death.

Main Methods:

  • 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for antiproliferation.
  • Annexin V-FITC/PI staining and flow cytometry for apoptosis and cell cycle analysis.
  • Western-blot assay to assess protein expression (cdc2, cyclins, Bcl-2, Bax, caspases).

Main Results:

  • Daphnoretin exhibited significant antiproliferative activity with an IC(50) of 3.89 μM after 72 hours.
  • Daphnoretin induced apoptosis and arrested the cell cycle at the G2/M phase.
  • Molecular analysis revealed down-regulation of cdc2, cyclin A, and cyclin B1, inhibition of Bcl-2, and induction of Bax, leading to cytochrome c release and caspase-3 activation.

Conclusions:

  • Daphnoretin effectively induces apoptosis and G2/M cell cycle arrest in HOS cells.
  • The mechanism involves the mitochondrial pathway, cytochrome c release, and activation of the caspase-9 and caspase-3 cascade.
  • Daphnoretin shows potential as a therapeutic agent for human osteosarcoma.